l-Dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia
暂无分享,去创建一个
G. Ransmayr | S. Bonelli | S B Bonelli | G Ransmayr | M Steffelbauer | T Lukas | C Lampl | M Deibl | C. Lampl | M. Deibl | M. Steffelbauer | T. Lukas
[1] S Fahn,et al. Committee. Unified Parkinson’s Disease Rating Scale. , 2001 .
[2] Alan Thomas,et al. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross‐sectional comparative study , 2003, Movement disorders : official journal of the Movement Disorder Society.
[3] E. Moro,et al. Acute Challenge with Apomorphine and Levodopa in Parkinsonism , 2000, European Neurology.
[4] G. C. Román,et al. Vascular dementia , 1993, Neurology.
[5] W. Poewe,et al. Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease , 2001, European Journal of Nuclear Medicine.
[6] S. Fahn. Unified Parkinson's Disease Rating Scale , 1987 .
[7] J. Nutt,et al. Evolution of the response to levodopa during the first 4 years of therapy , 2002, Annals of neurology.
[8] J. Trojanowski,et al. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases , 2002, Annals of neurology.
[9] I. McKeith,et al. SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders , 2003, Movement disorders : official journal of the Movement Disorder Society.
[10] P. Ince,et al. The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies , 1997, Acta neurologica Scandinavica.